Accelerating Drug Development with Precision ADME/PK Solutions
At HuaTeng Biotechnology, we deliver end-to-end ADME/PK profiling services to optimize drug discovery and development, ensuring robust pharmacokinetic and safety data for small molecules, biologics, and novel modalities. Our globally compliant studies bridge preclinical and clinical phases, empowering you to prioritize candidates, mitigate attrition risks, and meet regulatory milestones.
In Vitro ADME Screening
In Vivo Pharmacokinetics (PK)
Specialized Assays
Global Compliance: AAALAC-accredited facilities with IACUC oversight, aligned with EU Directive 2010/63/EU and USDA standards—ensuring full regulatory acceptance across major markets.
Advanced Imaging Capabilities: Integrated platforms including DSA, IVUS, angiography and micro-CT, enabling real-time evaluation of device performance and in vivo outcomes.
Custom Model Development: Species-specific animal models tailored to complex disease conditions, improving translational relevance and clinical predictability.
Integrated Histopathology Suite: SEM and TEM analysis supported by GLP-grade reporting, enabling seamless submission to PMDA, CE Mark and global regulatory authorities.